{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T10:33:48Z","timestamp":1792924428655,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"crossref","award":["9958"],"award-info":[{"award-number":["9958"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"crossref","award":["9958"],"award-info":[{"award-number":["9958"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"crossref","award":["9958"],"award-info":[{"award-number":["9958"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"crossref","award":["9958"],"award-info":[{"award-number":["9958"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-31867-5","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T11:53:40Z","timestamp":1769428420000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mitochondrial protective effects of ellagic acid in a rat model of sporadic Alzheimer\u2019s disease induced by STZ"],"prefix":"10.1038","volume":"16","author":[{"given":"Forouzan","family":"Khodaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Namavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Soutodeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsalan","family":"Hadipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freshteh","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohmmad Javad","family":"Khoshnoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8395-2944","authenticated-orcid":false,"given":"Marzieh","family":"Rashedinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"31867_CR1","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/jnr.24996","volume":"100","author":"A Tennakoon","year":"2022","unstructured":"Tennakoon, A. et al. Normal aging, motor neurone disease, and Alzheimer\u2019s disease are characterized by cortical changes in inflammatory cytokines. J. Neurosci. Res. 100, 653\u2013669 (2022).","journal-title":"J. Neurosci. Res."},{"key":"31867_CR2","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/molecules27061816","volume":"27","author":"ZR Chen","year":"2022","unstructured":"Chen, Z. R., Huang, J. B., Yang, S. L. & Hong, F. F. Role of cholinergic signaling in Alzheimer\u2019s disease. Molecules 27, 1816 (2022).","journal-title":"Molecules"},{"key":"31867_CR3","doi-asserted-by":"publisher","first-page":"951128","DOI":"10.3389\/fnins.2022.951128","volume":"16","author":"Q Wang","year":"2022","unstructured":"Wang, Q. & Xie, C. Microglia activation linking amyloid-\u03b2 drive tau spatial propagation in Alzheimer\u2019s disease. Front. NeuroSci. 16, 951128 (2022).","journal-title":"Front. NeuroSci."},{"key":"31867_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13024-023-00617-4","volume":"18","author":"CD Morrone","year":"2023","unstructured":"Morrone, C. D., Raghuraman, R., Hussaini, S. A. & Yu, W. H. Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer\u2019s disease. Mol. Neurodegeneration. 18, 27 (2023).","journal-title":"Mol. Neurodegeneration"},{"key":"31867_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-023-00640-5","volume":"18","author":"Y Inoue","year":"2023","unstructured":"Inoue, Y., Shue, F., Bu, G. & Kanekiyo, T. Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer\u2019s disease. Mol. Neurodegeneration. 18, 1\u201322 (2023).","journal-title":"Mol. Neurodegeneration"},{"key":"31867_CR6","doi-asserted-by":"publisher","first-page":"6954","DOI":"10.3390\/ijms23136954","volume":"23","author":"AV Blagov","year":"2022","unstructured":"Blagov, A. V. et al. Role of impaired mitochondrial dynamics processes in the pathogenesis of Alzheimer\u2019s disease. Int. J. Mol. Sci. 23, 6954 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"31867_CR7","doi-asserted-by":"publisher","first-page":"111828","DOI":"10.1016\/j.exger.2022.111828","volume":"164","author":"AB Reiss","year":"2022","unstructured":"Reiss, A. B. et al. The role of mitochondrial dysfunction in Alzheimer\u2019s disease: A potential pathway to treatment. Exp. Gerontol. 164, 111828 (2022).","journal-title":"Exp. Gerontol."},{"key":"31867_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","volume":"60","author":"A Nunomura","year":"2001","unstructured":"Nunomura, A. et al. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathology Experimental Neurol. 60, 759\u2013767 (2001).","journal-title":"J. Neuropathology Experimental Neurol."},{"key":"31867_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000276558","volume":"25","author":"MD Ferrer","year":"2010","unstructured":"Ferrer, M. D., Sureda, A., Mestre, A., Tur, J. A. & Pons, A. The double edge of reactive oxygen species as damaging and signaling molecules in HL60 cell culture. Cell. Physiol. Biochem. 25, 241\u2013252 (2010).","journal-title":"Cell. Physiol. Biochem."},{"key":"31867_CR10","first-page":"1630","volume":"1812","author":"RH Swerdlow","year":"2011","unstructured":"Swerdlow, R. H. Brain aging, Alzheimer\u2019s disease, and mitochondria. Biochim. Et Biophys. Acta (BBA)-Molecular Basis Disease. 1812, 1630\u20131639 (2011).","journal-title":"Biochim. Et Biophys. Acta (BBA)-Molecular Basis Disease"},{"key":"31867_CR11","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","volume":"1842","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease. Biochim. Biophys. Acta. 1842, 1240\u20131247. https:\/\/doi.org\/10.1016\/j.bbadis.2013.10.015 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"31867_CR12","doi-asserted-by":"publisher","first-page":"109295","DOI":"10.1016\/j.intimp.2022.109295","volume":"112","author":"S Ghaderi","year":"2022","unstructured":"Ghaderi, S. et al. p-Coumaric acid ameliorates cognitive and non-cognitive disturbances in a rat model of Alzheimer\u2019s disease: the role of oxidative stress and inflammation. Int. Immunopharmacol. 112, 109295 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"31867_CR13","doi-asserted-by":"publisher","first-page":"102484","DOI":"10.1016\/j.redox.2022.102484","volume":"57","author":"SP Rao","year":"2022","unstructured":"Rao, S. P. et al. Sulfanegen stimulates 3-mercaptopyruvate sulfurtransferase activity and ameliorates Alzheimer\u2019s disease pathology and oxidative stress in vivo. Redox Biol. 57, 102484 (2022).","journal-title":"Redox Biol."},{"key":"31867_CR14","doi-asserted-by":"publisher","first-page":"116954","DOI":"10.1016\/j.lfs.2019.116954","volume":"237","author":"F Khodaei","year":"2019","unstructured":"Khodaei, F., Rashedinia, M., Heidari, R., Rezaei, M. & Khoshnoud, M. J. Ellagic acid improves muscle dysfunction in cuprizone-induced demyelinated mice via mitochondrial Sirt3 regulation. Life Sci. 237, 116954 (2019).","journal-title":"Life Sci."},{"key":"31867_CR15","doi-asserted-by":"publisher","first-page":"e22564","DOI":"10.1002\/jbt.22564","volume":"34","author":"F Khodaei","year":"2020","unstructured":"Khodaei, F. et al. The effect of ellagic acid on spinal cord and sciatica function in a mice model of multiple sclerosis. J. Biochem. Mol. Toxicol. 34, e22564 (2020).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"31867_CR16","first-page":"29","volume":"6","author":"MM Ommati","year":"2020","unstructured":"Ommati, M. M. et al. Methylene blue treatment enhances mitochondrial function and locomotor activity in a C57BL\/6 mouse model of multiple sclerosis. Trends Pharm. Sci. 6, 29\u201342 (2020).","journal-title":"Trends Pharm. Sci."},{"key":"31867_CR17","first-page":"214","volume":"22","author":"AH Assaran","year":"2022","unstructured":"Assaran, A. H. et al. Ellagic acid prevents oxidative stress and memory deficits in a rat model of scopolamine-induced alzheimer\u2019s disease. Cent. Nerv. Syst. Agents Med. Chem. (Formerly Curr. Med. Chemistry-Central Nerv. Syst. Agents). 22, 214\u2013227 (2022).","journal-title":"Cent. Nerv. Syst. Agents Med. Chem. (Formerly Curr. Med. Chemistry-Central Nerv. Syst. Agents)"},{"key":"31867_CR18","doi-asserted-by":"publisher","first-page":"113848","DOI":"10.1016\/j.biopha.2022.113848","volume":"156","author":"Q Wang","year":"2022","unstructured":"Wang, Q., Botchway, B. O., Zhang, Y. & Liu, X. Ellagic acid activates the Keap1-Nrf2-ARE signaling pathway in improving Parkinson\u2019s disease: A review. Biomed. Pharmacother. 156, 113848 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"31867_CR19","unstructured":"Sarkaki, A., Farbood, Y., Dolatshahi, M., Mansouri, S. M. T. & Khodadadi, A. Neuroprotective effects of ellagic acid in a rat model of Parkinson\u2019s disease. Acta Med. Iranica, 494\u2013502 (2016)."},{"key":"31867_CR20","doi-asserted-by":"publisher","first-page":"175316","DOI":"10.1016\/j.ejphar.2022.175316","volume":"934","author":"M Bains","year":"2022","unstructured":"Bains, M., Kaur, J., Akhtar, A., Kuhad, A. & Sah, S. P. Anti-inflammatory effects of ellagic acid and vanillic acid against quinolinic acid-induced rat model of Huntington\u2019s disease by targeting IKK-NF-\u03baB pathway. Eur. J. Pharmacol. 934, 175316 (2022).","journal-title":"Eur. J. Pharmacol."},{"key":"31867_CR21","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.2174\/1381612826666201112144006","volume":"27","author":"N Javaid","year":"2021","unstructured":"Javaid, N. et al. Neuroprotective effects of ellagic acid in Alzheimer\u2019s disease: focus on underlying molecular mechanisms of therapeutic potential. Curr. Pharm. Des. 27, 3591\u20133601. https:\/\/doi.org\/10.2174\/1381612826666201112144006 (2021).","journal-title":"Curr. Pharm. Des."},{"key":"31867_CR22","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/advances\/nmab007","volume":"12","author":"A Gupta","year":"2021","unstructured":"Gupta, A. et al. Neuroprotective potential of ellagic acid: A critical review. Adv. Nutr. 12, 1211\u20131238. https:\/\/doi.org\/10.1093\/advances\/nmab007 (2021).","journal-title":"Adv. Nutr."},{"key":"31867_CR23","doi-asserted-by":"publisher","first-page":"116954","DOI":"10.1016\/j.lfs.2019.116954","volume":"237","author":"F Khodaei","year":"2019","unstructured":"Khodaei, F., Rashedinia, M., Heidari, R., Rezaei, M. & Khoshnoud, M. J. Ellagic acid improves muscle dysfunction in cuprizone-induced demyelinated mice via mitochondrial Sirt3 regulation. Life Sci. 237, 116954. https:\/\/doi.org\/10.1016\/j.lfs.2019.116954 (2019).","journal-title":"Life Sci."},{"key":"31867_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bbr.2016.05.046","volume":"311","author":"A Bahramian","year":"2016","unstructured":"Bahramian, A., Rastegar, K., Namavar, M. R. & Moosavi, M. Insulin potentiates the therapeutic effect of memantine against central STZ-induced spatial learning and memory deficit. Behav. Brain. Res. 311, 247\u2013254 (2016).","journal-title":"Behav. Brain. Res."},{"key":"31867_CR25","doi-asserted-by":"crossref","unstructured":"Khoshnoud, M. J., Siavashpour, A., Bakhshizadeh, M. & Rashedinia, M. Effects of sodium benzoate, a commonly used food preservative, on learning, memory, and oxidative stress in brain of mice. J. Biochem. Mol. Toxicol. 32, e22022 (2018).","DOI":"10.1002\/jbt.22022"},{"key":"31867_CR26","doi-asserted-by":"crossref","unstructured":"Rashedinia, M. et al. The effect of a traditional preparation containing Piper nigrum L. and Bunium persicum (Boiss.) B. Fedtsch. on immobility stress-induced memory loss in mice. BioMed Res. Int. 2021, 5577594 (2021).","DOI":"10.1155\/2021\/5577594"},{"key":"31867_CR27","doi-asserted-by":"publisher","first-page":"e22564","DOI":"10.1002\/jbt.22564","volume":"34","author":"F Khodaei","year":"2020","unstructured":"Khodaei, F. et al. The effect of ellagic acid on spinal cord and sciatica function in a mice model of multiple sclerosis. J. Biochem. Mol. Toxicol. 34, e22564. https:\/\/doi.org\/10.1002\/jbt.22564 (2020).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"31867_CR28","unstructured":"Heidari, R. et al. The hepatoprotection provided by taurine and glycine against antineoplastic drugs induced liver injury in an ex vivo model of normothermic recirculating isolated perfused rat liver. Vol. 2 (2016)."},{"key":"31867_CR29","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s00213-021-05826-7","volume":"238","author":"A Akhtar","year":"2021","unstructured":"Akhtar, A., Dhaliwal, J. & Sah, S. P. 7, 8-Dihydroxyflavone improves cognitive functions in ICV-STZ rat model of sporadic Alzheimer\u2019s disease by reversing oxidative stress, mitochondrial dysfunction, and insulin resistance. Psychopharmacology 238, 1991\u20132009 (2021).","journal-title":"Psychopharmacology"},{"key":"31867_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JAD-2006-9102","volume":"9","author":"N Lester-Coll","year":"2006","unstructured":"Lester-Coll, N. et al. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer\u2019s disease. J. Alzheimers Dis. 9, 13\u201333 (2006).","journal-title":"J. Alzheimers Dis."},{"key":"31867_CR31","doi-asserted-by":"publisher","first-page":"e37372","DOI":"10.1016\/j.heliyon.2024.e37372","volume":"10","author":"AB Jha","year":"2024","unstructured":"Jha, A. B., Chaube, U. J. & Jha, A. B. Ellagic acid improves the symptoms of early-onset Alzheimer\u2019s disease: behavioral and physiological correlates. Heliyon 10, e37372. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37372 (2024).","journal-title":"Heliyon"},{"key":"31867_CR32","doi-asserted-by":"publisher","first-page":"e107129","DOI":"10.1371\/journal.pone.0107129","volume":"9","author":"K Kysenius","year":"2014","unstructured":"Kysenius, K., Brunello, C. A. & Huttunen, H. J. Mitochondria and NMDA receptor-dependent toxicity of berberine sensitizes neurons to glutamate and rotenone injury. PloS One. 9, e107129 (2014).","journal-title":"PloS One"},{"key":"31867_CR33","unstructured":"Tom\u00e1s-Barberan, F. A., Esp\u00edn, J. C. & Garc\u00eda-Conesa, M. T. In Chemistry and Biology of Ellagitannins 273\u2013297."},{"key":"31867_CR34","doi-asserted-by":"publisher","unstructured":"Long, J. et al. Ellagic acid bioavailability and metabolism after single dose consumption of pure ellagic acid versus pomegranate juice (P06-031-19). Curr. Dev. Nutr. 3 https:\/\/doi.org\/10.1093\/cdn\/nzz031.P06-031-19 (2019).","DOI":"10.1093\/cdn\/nzz031.P06-031-19"},{"key":"31867_CR35","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3945\/an.116.012575","volume":"7","author":"I Kang","year":"2016","unstructured":"Kang, I., Buckner, T., Shay, N. F., Gu, L. & Chung, S. Improvements in metabolic health with consumption of ellagic acid and subsequent conversion into urolithins: evidence and mechanisms. Adv. Nutr. (Bethesda Md). 7, 961\u2013972. https:\/\/doi.org\/10.3945\/an.116.012575 (2016).","journal-title":"Adv. Nutr. (Bethesda Md)"},{"key":"31867_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0304-3835(87)90007-3","volume":"34","author":"RW Teel","year":"1987","unstructured":"Teel, R. W. Distribution and metabolism of ellagic acid in the mouse following intraperitoneal administration. Cancer Lett. 34, 165\u2013171 (1987).","journal-title":"Cancer Lett."},{"key":"31867_CR37","doi-asserted-by":"publisher","first-page":"18923","DOI":"10.3390\/molecules191118923","volume":"19","author":"L Yan","year":"2014","unstructured":"Yan, L., Yin, P., Ma, C. & Liu, Y. Method development and validation for pharmacokinetic and tissue distributions of ellagic acid using ultrahigh performance liquid chromatography-tandem mass spectrometry (UPLC-MS\/MS). Molecules (Basel Switzerland). 19, 18923\u201318935. https:\/\/doi.org\/10.3390\/molecules191118923 (2014).","journal-title":"Molecules (Basel Switzerland)"},{"key":"31867_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cytogfr.2014.09.002","volume":"26","author":"Y Yang","year":"2015","unstructured":"Yang, Y. et al. An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders. Cytokine Growth Factor Rev. 26, 47\u201357. https:\/\/doi.org\/10.1016\/j.cytogfr.2014.09.002 (2015).","journal-title":"Cytokine Growth Factor Rev."},{"key":"31867_CR39","first-page":"709","volume":"41","author":"J He","year":"2018","unstructured":"He, J. et al. Neurochemical changes in the hippocampus and prefrontal cortex associated with electroacupuncture for learning and memory impairment. Int. J. Mol. Med. 41, 709\u2013716 (2018).","journal-title":"Int. J. Mol. Med."},{"key":"31867_CR40","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1080\/1028415X.2021.1954293","volume":"25","author":"V Jain","year":"2022","unstructured":"Jain, V. et al. Punicalagin and ellagic acid containing Punica granatum L. fruit rind extract prevents vincristine-induced neuropathic pain in rats: an in silico and in vivo evidence of GABAergic action and cytokine inhibition. Nutr. Neurosci. 25, 2149\u20132166 (2022).","journal-title":"Nutr. Neurosci."},{"key":"31867_CR41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fncel.2020.00235","volume":"14","author":"J Park","year":"2020","unstructured":"Park, J. et al. Streptozotocin induces Alzheimer\u2019s disease-like pathology in hippocampal neuronal cells via CDK5\/Drp1-mediated mitochondrial fragmentation. Front. Cell. Neurosci. 14, 235 (2020).","journal-title":"Front. Cell. Neurosci."},{"key":"31867_CR42","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s12035-021-02627-z","volume":"59","author":"FC Teixeira","year":"2022","unstructured":"Teixeira, F. C. et al. Investigating the effect of inosine on brain purinergic receptors and neurotrophic and neuroinflammatory parameters in an experimental model of Alzheimer\u2019s disease. Mol. Neurobiol. 59, 841\u2013855. https:\/\/doi.org\/10.1007\/s12035-021-02627-z (2022).","journal-title":"Mol. Neurobiol."},{"key":"31867_CR43","doi-asserted-by":"crossref","unstructured":"Zhang, X. et al. Anti-inflammatory action of BT75, a novel RAR\u03b1 agonist, in cultured microglia and in an experimental mouse model of Alzheimer\u2019s disease. Neurochem. Res., 1\u201313 (2023).","DOI":"10.1007\/s11064-023-03888-x"},{"key":"31867_CR44","unstructured":"Malenka, R. C. Biological Psychiatry. 2S-2S (Elsevier Science Inc)."},{"key":"31867_CR45","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1055\/s-0043-108552","volume":"67","author":"N Bansal","year":"2017","unstructured":"Bansal, N., Yadav, P. & Kumar, M. Ellagic acid administration negated the development of streptozotocin-induced memory deficit in rats. Drug Res. 67, 425\u2013431 (2017).","journal-title":"Drug Res."},{"key":"31867_CR46","unstructured":"Kaur, J. & Kumar, M. & Bansal, N. Ellagic acid administration reverses colchicine-induced dementia in rats. (2016)."},{"key":"31867_CR47","first-page":"3591","volume":"27","author":"N Javaid","year":"2021","unstructured":"Javaid, N. et al. Neuroprotective effects of ellagic acid in Alzheimer\u2019s disease: focus on underlying molecular mechanisms of therapeutic potential. Curr. Pharm. Design. 27, 3591\u20133601 (2021).","journal-title":"Curr. Pharm. Design"},{"key":"31867_CR48","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s11010-022-04627-6","volume":"478","author":"S Yakobov","year":"2023","unstructured":"Yakobov, S. et al. Ellagic acid inhibits mitochondrial fission protein Drp-1 and cell proliferation in cancer. Mol. Cell. Biochem. 478, 2029\u20132040 (2023).","journal-title":"Mol. Cell. Biochem."},{"key":"31867_CR49","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s40199-019-00309-9","volume":"27","author":"R Ebrahimi","year":"2019","unstructured":"Ebrahimi, R. et al. Ellagic acid reduces methotrexate-induced apoptosis and mitochondrial dysfunction via up-regulating Nrf2 expression and inhibiting the I\u0138B\u03b1\/NF\u0138B in rats. DARU J. Pharm. Sci. 27, 721\u2013733. https:\/\/doi.org\/10.1007\/s40199-019-00309-9 (2019).","journal-title":"DARU J. Pharm. Sci."},{"key":"31867_CR50","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.toxrep.2018.02.017","volume":"5","author":"F Firdaus","year":"2018","unstructured":"Firdaus, F., Zafeer, M. F., Anis, E., Ahmad, M. & Afzal, M. Ellagic acid attenuates arsenic induced neuro-inflammation and mitochondrial dysfunction associated apoptosis. Toxicol. Rep. 5, 411\u2013417. https:\/\/doi.org\/10.1016\/j.toxrep.2018.02.017 (2018).","journal-title":"Toxicol. Rep."},{"key":"31867_CR51","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3390\/antiox13111296","volume":"13","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Ellagic acid reduces cadmium exposure-induced apoptosis in HT22 cells via inhibiting oxidative stress and mitochondrial dysfunction and activating Nrf2\/HO-1 pathway. Antioxidants 13, 1296 (2024).","journal-title":"Antioxidants"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31867-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31867-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31867-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:04:20Z","timestamp":1769508260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31867-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31867"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31867-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"3 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data used in this study were obtained from animal experiments conducted and analyzed by the authors. All procedures involving animals were approved by the Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences. (Approval No. 9958 and carried out in accordance with institutional guidelines and national regulations for the care and use of laboratory animals. We have included a statement confirming that the study has been reported in accordance with the ARRIVE guidelines, as per your editorial policy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3498"}}